Merck appoints VP, therapeutic area head

Aileen Pangan will lead Merck’s new immunology therapeutic unit.

Lecia Bushak

March 8, 2022

1:55 pm

Merck has appointed Aileen Pangan as VP, therapeutic area head, immunology, global clinical development. In that role, Pangan will help lead the company’s new immunology therapeutic area and late-stage clinical development.

Pangan brings 17 years of experience in clinical trials, most recently serving as AbbVie’s executive medical director, immunology clinical development. There, she led development teams in rheumatology, gastroenterology and dermatology.

From Our Partners

Prioritizing audience quality and contextual environment in POC marketing

Partner Content

Prioritizing audience quality and contextual environment in POC marketing

Despite the growing popularity of POC marketing via EHR platforms, this channel remains highly fragmented. For omnichannel marketers, that fragmentation can represent challenges in finding scale, transparency, and uniformity in targeting and performance reporting.

Want to better engage patients with complex diagnoses? Embrace digital.

Partner Content

Want to better engage patients with complex diagnoses? Embrace digital.

Patients often struggle to find specialist care, delaying needed treatment. Digital tools can help.

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.